CN

田斯丹

助理研究员(自然科学)

Supervisor of Master's Candidates

Gender:Male

Status:Employed

Department:School of Life Science and Technology

Education Level:Postgraduate (Doctoral)

Degree:Doctoral Degree in Science

Discipline:Biomedical Engineering

Details >

Paper Publications

Reactive oxygen species-responsive and Raman-traceable hydrogel combining photodynamic and immune therapy for postsurgical cancer treatment

Release time:2023-07-17 Hits:

Indexed by:Article

Journal:Nature Communications

Included Journals:SCI

Volume:13

ISSN No.:2041-1723

DOI number:10.1038/s41467-022-32160-z

Date of Publication:2022-08-04

Impact Factor:14.919

Abstract:Combining immune checkpoint blockade (ICB) therapy with photodynamic therapy (PDT) holds great potential in treating immunologically “cold” tumors, but photo-generated reactive oxygen species (ROS) can inevitably damage co-administered ICB antibodies, hence hampering the therapeutic outcome. Here we create a ROS-responsive hydrogel to realize the sustained co-delivery of photosensitizers and ICB antibodies. During PDT, the hydrogel skeleton poly(deca-4,6-diynedioic acid) (PDDA) protects ICB antibodies by scavenging the harmful ROS, and at the same time, triggers the gradual degradation of the hydrogel to release the drugs in a controlled manner. More interestingly, we can visualize the ROS-responsive hydrogel degradation by Raman imaging, given the ultrastrong and degradation-correlative Raman signal of PDDA in the cellular silent window. A single administration of the hydrogel not only completely inhibits the long-term postoperative recurrence and metastasis of 4T1-tumor-bearing mice, but also effectively restrains the growth of re-challenged tumors. The PDDA-based ROS-responsive hydrogel herein paves a promising way for the durable synergy of PDT and ICB therapy.

Links to published journals:https://www.nature.com/articles/s41467-022-32160-z

Copyright © 2017 Huazhong University of Science & Technology

Click:times | The Founding Time:.. | The Last Update Time:.. | MOBILE Version